NL8120270A - Self-supporting polymeric diffusion matrix contg. terbutaline - comprising polar plasticiser, polyvinyl alcohol and polyvinyl pyrrolidone - Google Patents
Self-supporting polymeric diffusion matrix contg. terbutaline - comprising polar plasticiser, polyvinyl alcohol and polyvinyl pyrrolidone Download PDFInfo
- Publication number
- NL8120270A NL8120270A NL8120270A NL8120270A NL8120270A NL 8120270 A NL8120270 A NL 8120270A NL 8120270 A NL8120270 A NL 8120270A NL 8120270 A NL8120270 A NL 8120270A NL 8120270 A NL8120270 A NL 8120270A
- Authority
- NL
- Netherlands
- Prior art keywords
- weight
- diffusion matrix
- patient
- polyvinyl alcohol
- self
- Prior art date
Links
- 239000011159 matrix material Substances 0.000 title claims abstract description 63
- 238000009792 diffusion process Methods 0.000 title claims abstract description 55
- 239000004372 Polyvinyl alcohol Substances 0.000 title claims abstract description 25
- 229920002451 polyvinyl alcohol Polymers 0.000 title claims abstract description 25
- 239000004014 plasticizer Substances 0.000 title claims abstract description 20
- 229920000036 polyvinylpyrrolidone Polymers 0.000 title claims abstract description 18
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 title claims abstract description 18
- 239000001267 polyvinylpyrrolidone Substances 0.000 title claims abstract description 17
- XWTYSIMOBUGWOL-UHFFFAOYSA-N (+-)-Terbutaline Chemical compound CC(C)(C)NCC(O)C1=CC(O)=CC(O)=C1 XWTYSIMOBUGWOL-UHFFFAOYSA-N 0.000 title claims abstract description 12
- 229960000195 terbutaline Drugs 0.000 title claims abstract description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 66
- 239000002202 Polyethylene glycol Substances 0.000 claims abstract description 12
- 229920001223 polyethylene glycol Polymers 0.000 claims abstract description 12
- 238000013268 sustained release Methods 0.000 claims abstract description 10
- 239000012730 sustained-release form Substances 0.000 claims abstract description 10
- 229940124630 bronchodilator Drugs 0.000 claims abstract description 5
- 239000000203 mixture Substances 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 15
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 claims description 14
- 230000000694 effects Effects 0.000 claims description 9
- 229960005309 estradiol Drugs 0.000 claims description 8
- 229930182833 estradiol Natural products 0.000 claims description 8
- 229960001802 phenylephrine Drugs 0.000 claims description 8
- SONNWYBIRXJNDC-VIFPVBQESA-N phenylephrine Chemical compound CNC[C@H](O)C1=CC=CC(O)=C1 SONNWYBIRXJNDC-VIFPVBQESA-N 0.000 claims description 8
- GJSURZIOUXUGAL-UHFFFAOYSA-N Clonidine Chemical compound ClC1=CC=CC(Cl)=C1NC1=NCCN1 GJSURZIOUXUGAL-UHFFFAOYSA-N 0.000 claims description 7
- 229960002896 clonidine Drugs 0.000 claims description 7
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 claims description 7
- 229960002179 ephedrine Drugs 0.000 claims description 7
- -1 estradiol ester Chemical class 0.000 claims description 7
- DBAKFASWICGISY-BTJKTKAUSA-N Chlorpheniramine maleate Chemical compound OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 DBAKFASWICGISY-BTJKTKAUSA-N 0.000 claims description 6
- DLNKOYKMWOXYQA-UHFFFAOYSA-N dl-pseudophenylpropanolamine Natural products CC(N)C(O)C1=CC=CC=C1 DLNKOYKMWOXYQA-UHFFFAOYSA-N 0.000 claims description 6
- DLNKOYKMWOXYQA-APPZFPTMSA-N phenylpropanolamine Chemical compound C[C@@H](N)[C@H](O)C1=CC=CC=C1 DLNKOYKMWOXYQA-APPZFPTMSA-N 0.000 claims description 6
- 229960000395 phenylpropanolamine Drugs 0.000 claims description 6
- 229940046978 chlorpheniramine maleate Drugs 0.000 claims description 5
- 230000003111 delayed effect Effects 0.000 claims description 5
- 150000002159 estradiols Chemical class 0.000 claims description 3
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 claims description 2
- 230000001387 anti-histamine Effects 0.000 claims description 2
- 239000000739 antihistaminic agent Substances 0.000 claims description 2
- 230000004531 blood pressure lowering effect Effects 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 2
- 239000000850 decongestant Substances 0.000 claims 2
- 238000013265 extended release Methods 0.000 claims 1
- 229920006389 polyphenyl polymer Polymers 0.000 claims 1
- 230000037317 transdermal delivery Effects 0.000 abstract description 2
- 235000019422 polyvinyl alcohol Nutrition 0.000 abstract 2
- 230000002459 sustained effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 description 27
- 229940079593 drug Drugs 0.000 description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 229920000642 polymer Polymers 0.000 description 7
- 229920000936 Agarose Polymers 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- 239000010410 layer Substances 0.000 description 5
- 229920001817 Agar Polymers 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- 239000008240 homogeneous mixture Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 229910001220 stainless steel Inorganic materials 0.000 description 3
- 239000010935 stainless steel Substances 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- VQHQLBARMFAKSV-AANPDWTMSA-N [(8r,9s,13s,14s,17s)-3-acetyloxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] acetate Chemical compound C1CC2=CC(OC(C)=O)=CC=C2[C@@H]2[C@@H]1[C@@H]1CC[C@H](OC(=O)C)[C@@]1(C)CC2 VQHQLBARMFAKSV-AANPDWTMSA-N 0.000 description 2
- 238000001647 drug administration Methods 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- 229920002818 (Hydroxyethyl)methacrylate Polymers 0.000 description 1
- NZJXADCEESMBPW-UHFFFAOYSA-N 1-methylsulfinyldecane Chemical compound CCCCCCCCCCS(C)=O NZJXADCEESMBPW-UHFFFAOYSA-N 0.000 description 1
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 description 1
- GNSFRPWPOGYVLO-UHFFFAOYSA-N 3-hydroxypropyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCO GNSFRPWPOGYVLO-UHFFFAOYSA-N 0.000 description 1
- QZPSOSOOLFHYRR-UHFFFAOYSA-N 3-hydroxypropyl prop-2-enoate Chemical compound OCCCOC(=O)C=C QZPSOSOOLFHYRR-UHFFFAOYSA-N 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 229920002799 BoPET Polymers 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 1
- 239000005041 Mylar™ Substances 0.000 description 1
- 241000237502 Ostreidae Species 0.000 description 1
- 229920002845 Poly(methacrylic acid) Polymers 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 241000978776 Senegalia senegal Species 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 229940124532 absorption promoter Drugs 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 150000001241 acetals Chemical class 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000012790 adhesive layer Substances 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000003182 bronchodilatating effect Effects 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 210000003679 cervix uteri Anatomy 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 239000003118 drug derivative Substances 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- VSEAAEQOQBMPQF-UHFFFAOYSA-N morpholin-3-one Chemical compound O=C1COCCN1 VSEAAEQOQBMPQF-UHFFFAOYSA-N 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 235000020636 oyster Nutrition 0.000 description 1
- XUWHAWMETYGRKB-UHFFFAOYSA-N piperidin-2-one Chemical compound O=C1CCCCN1 XUWHAWMETYGRKB-UHFFFAOYSA-N 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920001515 polyalkylene glycol Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 210000000707 wrist Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Gynecology & Obstetrics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (18)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16700880A | 1980-07-09 | 1980-07-09 | |
| US06/167,010 US4292301A (en) | 1979-08-14 | 1980-07-09 | Polymeric diffusion matrix containing ephedrine |
| US06/167,101 US4294820A (en) | 1979-08-14 | 1980-07-09 | Polymeric diffusion matrix containing phenylephrine |
| US16701080 | 1980-07-09 | ||
| US06/167,009 US4289749A (en) | 1979-08-14 | 1980-07-09 | Polymeric diffusion matrix containing phenylpropanolamine |
| US16710480 | 1980-07-09 | ||
| US16700880 | 1980-07-09 | ||
| US16710180 | 1980-07-09 | ||
| US06/167,106 US4292303A (en) | 1979-08-14 | 1980-07-09 | Polymeric diffusion matrix containing clonidine |
| US16710680 | 1980-07-09 | ||
| US16700980 | 1980-07-09 | ||
| US06/167,104 US4292302A (en) | 1979-08-14 | 1980-07-09 | Polymeric diffusion matrix containing terbutaline |
| US16772980 | 1980-07-11 | ||
| US06/167,729 US4291014A (en) | 1979-01-11 | 1980-07-11 | Polymeric diffusion matrix containing estradiol diacetate |
| US21740080 | 1980-12-17 | ||
| US06/217,400 US4321252A (en) | 1979-08-14 | 1980-12-17 | Polymeric diffusion matrix containing ester derivatives of estradiol |
| PCT/US1981/000893 WO1982000099A1 (en) | 1980-07-09 | 1981-06-26 | Polymeric diffusion matrix for administration of drugs |
| US8100893 | 1981-06-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL8120270A true NL8120270A (en) | 1982-06-01 |
Family
ID=41698406
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL8120270A NL8120270A (en) | 1980-07-09 | 1981-06-26 | Self-supporting polymeric diffusion matrix contg. terbutaline - comprising polar plasticiser, polyvinyl alcohol and polyvinyl pyrrolidone |
Country Status (13)
| Country | Link |
|---|---|
| JP (1) | JPS57500980A (zh) |
| AU (1) | AU7415181A (zh) |
| BE (1) | BE889549A (zh) |
| CA (1) | CA1163559A (zh) |
| CH (1) | CH658597A5 (zh) |
| DE (1) | DE3152182A1 (zh) |
| FR (1) | FR2486397A1 (zh) |
| GB (1) | GB2089210B (zh) |
| IT (1) | IT1237327B (zh) |
| NL (1) | NL8120270A (zh) |
| NO (1) | NO153638C (zh) |
| SE (1) | SE447448B (zh) |
| WO (1) | WO1982000099A1 (zh) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58206751A (ja) * | 1982-05-26 | 1983-12-02 | 日石三菱株式会社 | 創傷被覆材 |
| FR2532546B1 (fr) * | 1982-09-07 | 1985-12-27 | Biotrol Sa Lab | Pate pour la protection de la peau |
| FR2548021B1 (fr) * | 1983-06-29 | 1986-02-28 | Dick P R | Compositions pharmaceutiques dermiques a action prolongee et continue a base d'acides gras essentiels |
| DE3409079A1 (de) * | 1984-03-13 | 1985-09-19 | Bayer Ag, 5090 Leverkusen | Medizinische pflaster |
| SE457326B (sv) * | 1986-02-14 | 1988-12-19 | Lejus Medical Ab | Foerfarande foer framstaellning av en snabbt soenderfallande kaerna innehaallande bl a mikrokristallin cellulosa |
| US4860543A (en) * | 1986-08-08 | 1989-08-29 | Helix Technology Corporation | Vibration isolation system for a linear reciprocating machine |
| SU1705319A1 (ru) * | 1987-10-23 | 1992-01-15 | Всесоюзный Научно-Исследовательский Институт Биотехнологии | Состав полимерной диффузионной матрицы дл трансдермального введени лекарственных веществ |
| IT1261305B (it) * | 1993-06-22 | 1996-05-14 | Gevipi Ag | Dispositivo smorzatore di vibrazioni e di rumore, per impianti idraulici |
| DE4429667C2 (de) * | 1994-08-20 | 1996-07-11 | Lohmann Therapie Syst Lts | Estradiol-TTS mit wasserbindenden Zusätzen und Verfahren zu seiner Herstellung |
| US6719997B2 (en) | 2000-06-30 | 2004-04-13 | Dermatrends, Inc. | Transdermal administration of pharmacologically active amines using hydroxide-releasing agents as permeation enhancers |
| US6673363B2 (en) | 1999-12-16 | 2004-01-06 | Dermatrends, Inc. | Transdermal and topical administration of local anesthetic agents using basic enhancers |
| AU2727801A (en) * | 1999-12-16 | 2001-06-25 | Dermatrends, Inc. | Transdermal administration of phenylpropanolamine |
| US6602912B2 (en) | 2000-06-30 | 2003-08-05 | Dermatrends, Inc. | Transdermal administration of phenylpropanolamine |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2693438A (en) * | 1951-02-21 | 1954-11-02 | Norwich Pharma Co | Preformed, nonadherent films for application to open lesions |
| US2804073A (en) * | 1953-01-26 | 1957-08-27 | Protective Teatments Inc | Fluid surgical dressing |
| BE638231A (zh) * | 1962-03-16 | |||
| US3214338A (en) * | 1964-07-31 | 1965-10-26 | Ehrlich Joseph Ronald | Medicament releasing film-forming ointments and process of making |
| SU219116A1 (ru) * | 1965-11-26 | 1973-03-20 | А. А. Вишневский, Т. Т. Даурова, М. И. Долгина, И. А. Паников, Ф. П. Сидельковска , М. И. Шрайбер | Пленка для первичной обработки ожоговой поверхности |
| DE1617282A1 (de) * | 1965-11-30 | 1975-02-06 | Astra Pharma Prod | Vorrichtung zur lokalanaesthetisierung durch oertliche aufbringung und verfahren zur herstellung dieser vorrichtung |
| GB1213295A (en) * | 1967-04-27 | 1970-11-25 | Boots Pure Drug Co Ltd | Improvements in therapeutic compositions for topical application |
| FR2047874A6 (zh) * | 1969-06-10 | 1971-03-19 | Nouvel Lucien | |
| US3577516A (en) * | 1969-12-02 | 1971-05-04 | Nat Patent Dev Corp | Preparation of spray on bandage |
| DE2012775C3 (de) * | 1970-03-18 | 1973-10-04 | V.P. Variopharm Gmbh Herstellung Und Vertrieb Pharmazeutischer, Kosmetischer Und Chemischer Erzeugnisse, 6656 Einoed | Salbenfohe und Verfahren zu ihrer Herstellung |
| US3892905A (en) * | 1970-08-12 | 1975-07-01 | Du Pont | Cold water soluble plastic films |
| US4210633A (en) * | 1978-10-20 | 1980-07-01 | Eli Lilly And Company | Flurandrenolide film formulation |
| IL59063A (en) * | 1979-01-11 | 1983-12-30 | Key Pharma | Polymeric diffusion matrix for release of pharmaceutical dosage |
-
1981
- 1981-06-24 CA CA000380505A patent/CA1163559A/en not_active Expired
- 1981-06-26 CH CH1456/82A patent/CH658597A5/de not_active IP Right Cessation
- 1981-06-26 JP JP56502416A patent/JPS57500980A/ja active Pending
- 1981-06-26 AU AU74151/81A patent/AU7415181A/en not_active Abandoned
- 1981-06-26 NL NL8120270A patent/NL8120270A/nl unknown
- 1981-06-26 DE DE813152182T patent/DE3152182A1/de not_active Withdrawn
- 1981-06-26 WO PCT/US1981/000893 patent/WO1982000099A1/en active Application Filing
- 1981-06-26 GB GB8206466A patent/GB2089210B/en not_active Expired
- 1981-07-08 BE BE0/205347A patent/BE889549A/fr not_active IP Right Cessation
- 1981-07-09 FR FR8113518A patent/FR2486397A1/fr active Pending
-
1982
- 1982-02-24 IT IT8219833A patent/IT1237327B/it active
- 1982-03-04 SE SE8201337A patent/SE447448B/sv not_active IP Right Cessation
- 1982-03-08 NO NO820722A patent/NO153638C/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CH658597A5 (de) | 1986-11-28 |
| GB2089210B (en) | 1984-09-05 |
| FR2486397A1 (fr) | 1982-01-15 |
| JPS57500980A (zh) | 1982-06-03 |
| AU7415181A (en) | 1982-02-02 |
| SE447448B (sv) | 1986-11-17 |
| CA1163559A (en) | 1984-03-13 |
| SE8201337L (en) | 1982-03-04 |
| NO153638B (no) | 1986-01-20 |
| BE889549A (fr) | 1981-11-03 |
| IT8219833A0 (it) | 1982-02-24 |
| DE3152182A1 (de) | 1983-02-10 |
| GB2089210A (en) | 1982-06-23 |
| NO153638C (no) | 1986-05-07 |
| NO820722L (no) | 1982-03-08 |
| WO1982000099A1 (en) | 1982-01-21 |
| IT1237327B (it) | 1993-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2329128C (en) | Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces | |
| US4294820A (en) | Polymeric diffusion matrix containing phenylephrine | |
| US20160101061A1 (en) | Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces | |
| US6103266A (en) | Pharmaceutical gel preparation applicable to mucosal surfaces and body tissues | |
| JP2656338B2 (ja) | 口腔粘膜貼付製剤 | |
| US20050048102A1 (en) | Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces | |
| AU764912B2 (en) | Oral transmucosal delivery of drugs or any other ingredients via the inner buccal cavity | |
| US20120121724A1 (en) | Film comprising therapeutic agents | |
| NL8120270A (en) | Self-supporting polymeric diffusion matrix contg. terbutaline - comprising polar plasticiser, polyvinyl alcohol and polyvinyl pyrrolidone | |
| CA2493899A1 (en) | Controlled release modifying complex and pharmaceutical compositions thereof | |
| KR20080084858A (ko) | 구강 경점막 전달을 위한 생접착성 약물 제형 | |
| JP2005504763A (ja) | 医薬および他の活性な化合物の制御された投与のための粘膜接着性腐食性薬物送達デバイス | |
| CZ282557B6 (cs) | Způsob výroby transdermálního terapeutického systému s buprenorfinem jako aktivní součástí | |
| JP7091477B2 (ja) | エダラボン医薬組成物 | |
| WO2007120868A2 (en) | Bioavailability enhancement of lipophilic drug by use solvent system | |
| WO2004110445A1 (ja) | フェンタニル含有口腔粘膜貼付剤 | |
| KR20010033368A (ko) | 레보시멘단의 점막투여 제형 | |
| JPH02149514A (ja) | 医薬部材 | |
| KR100841877B1 (ko) | 국소적으로 가용화 된 난용성 약물의 제어 방출형 제제조성물 및 그의 제조 방법 | |
| JP2507068B2 (ja) | 経皮吸収製剤 | |
| JP2003519641A (ja) | 局所的薬用生体接着剤組成物、並びにその使用法および調製法 | |
| KR100190450B1 (ko) | 키토산을 이용한 매트릭스형 경피흡수제제 | |
| AU769500B2 (en) | Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces | |
| KR20030045473A (ko) | 점막부착성을 가지는 의약품 조성물 | |
| KR20240023530A (ko) | 아픽사반 필름 생성물 및 이의 용도 |